All Posts: research
-
Georgetown’s Center for Innovation in Global Health, in Partnership with the Government of Malawi, Leverages Emerging Tools To Accelerate an End to National HIV Epidemic
Georgetown University’s Center for Innovation in Global Health (CIGH), in partnership with the Republic of Malawi’s Ministry of Health, will advance research and policy toward the scale-up of long-acting injectable pre-exposure prophylaxis (PrEP) drugs to prevent HIV in the African country.
Category: News Release
-
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
The Curious Brain: Interdisciplinary Solutions for the Complex Problems of Neuroscience
Georgetown’s Interdisciplinary Program in Neuroscience offers doctoral students the ability to see neuroscience through the lens of multiple disciplines, not only allowing for the possibility of broadening or shifting their focus, but actively facilitating it.
Category: GUMC Stories
-
A New Understanding of How the Brain Processes and Stores Words We Hear
Georgetown University Medical Center neuroscientists say the brain’s auditory lexicon, a catalog of verbal language, is actually located in the front of the primary auditory cortex, not in back of it — a finding that upends a century-long understanding of this area of the brain. The new understanding matters because it may impact recovery and rehabilitation following a brain injury such as a stroke.
Category: News Release
-
Research To Help Patients Make Informed Decisions About Breast MRI
While many people think that breast cancer screening and mammography are synonymous, Claire Conley, PhD, wants people to know that women who are at higher than average risk for breast cancer may also receive a breast MRI.
Category: GUMC Stories
-
Researchers Develop Method to Monitor Cancer Radiotherapy Effects at the Cellular Level
Using complex molecular tools, Georgetown Lombardi researchers have determined how to measure, in real time, the effect that radiation treatment for cancer can have at the cellular level on surrounding healthy tissue.
Category: News Release
-
Novel Research Shows Older Breast Cancer Survivors Experience Accelerated Aging, Worse Functional Outcomes
In a new multicenter study, researchers from Georgetown University’s Lombardi Comprehensive Cancer Center, the Medical College of Wisconsin (MCW), UCLA and several other leading cancer centers from across the nation examined whether cancer and its treatments accelerate aging.
Category: News Release
-
Determining How a Sugar Molecule Can Affect Cancer Cell Response to Chemoradiotherapy
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues who have been exploring the complexities of biochemical pathways involved in cancer development have found that a form of glucose, a type of sugar, is intricately linked to a pathway used to build DNA molecules. When this pathway is overactive, it can lead to cancer and resistance to chemoradiotherapy.
Category: News Release
-
Veterans Exposed to Agent Orange May Be at Increased Risk of Developing Progressive Blood Cancers
Research conducted at Georgetown University’s Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins. When MPNs progress, they can become deadly leukemias.
Category: News Release
-
Types of Bacteria Vary Widely in Tumors of People with Early vs. Late-Onset Colorectal Cancer
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center studied the microbiome of people with colorectal cancer and found the makeup of the bacteria, fungi and viruses in a person’s tumor varied significantly depending on whether they were diagnosed with early onset disease (age 45 or younger) or late-onset disease (age 65 or older). These results may help answer the riddle of why more young people are developing colorectal cancer, particularly those who have no known identifiable risk factors for the disease.
Category: News Release